SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2022$5,146,855
-55.8%
30,399
-51.1%
0.09%
-55.1%
Q3 2022$11,642,000
+9.0%
62,221
+9.5%
0.20%
-4.8%
Q1 2022$10,684,000
+905.1%
56,803
+1315.8%
0.21%
+642.9%
Q4 2021$1,063,000
-8.3%
4,0120.0%0.03%
+33.3%
Q3 2021$1,159,000
-63.5%
4,012
-74.8%
0.02%
-63.8%
Q2 2021$3,176,000
-59.8%
15,912
-60.8%
0.06%
-57.0%
Q1 2021$7,893,000
+1.5%
40,6000.0%0.14%
-4.9%
Q4 2020$7,780,000
+29.9%
40,6000.0%0.14%
-20.7%
Q3 2020$5,990,000
+19.3%
40,6000.0%0.18%
-25.4%
Q2 2020$5,019,00040,6000.24%
Other shareholders
REPLIGEN CORP shareholders Q1 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders